LINC001133 was predominantly expressed in a less aggressive cluster in primary cancer cells, while MEG3 was primarily expressed in a metastatic cancer cell cluster, which displayed increased EMT signatures and was potentially leading cancer cell metastasis. The gene discussed is MEG3; the disease is cancer.